{"id":29193,"date":"2004-06-01T00:00:00","date_gmt":"2004-06-01T00:00:00","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/fator-vii-ativado-recombinante-para-hemorragia-uterina-grave-apos-quimioterapia-numa-mulher-com-leucemia-mieloide-aguda\/"},"modified":"2024-06-06T19:13:20","modified_gmt":"2024-06-06T19:13:20","slug":"fator-vii-ativado-recombinante-para-hemorragia-uterina-grave-apos-quimioterapia-numa-mulher-com-leucemia-mieloide-aguda","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/pt-pt\/resources\/fator-vii-ativado-recombinante-para-hemorragia-uterina-grave-apos-quimioterapia-numa-mulher-com-leucemia-mieloide-aguda\/","title":{"rendered":"Fator VII ativado recombinante para hemorragia uterina grave ap\u00f3s quimioterapia numa mulher com leucemia mieloide aguda."},"content":{"rendered":"\n<p><span style=\"font-size: 9pt; font-family: Arial;\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Erikci+AA%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Erikci AA<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Ozturk+A%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Ozturk A<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Sayan+O%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Sayan O<\/span>\n<\/a>. <span style=\"color: windowtext;\">Blood Coagul Fibrinolysis.<\/span> 2006 Jun;17(4):323-4.<\/span><\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Erikci AA , Ozturk A , Sayan O . Blood Coagul Fibrinolysis. 2006 Jun;17(4):323-4.<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[248],"tags":[],"class_list":["post-29193","resources","type-resources","status-publish","hentry","category-drogas"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/resources\/29193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/media?parent=29193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/categories?post=29193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/tags?post=29193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}